Quick View
| Metric | Current Period | Same Period Last Year | YoY |
|---|---|---|---|
| Revenue | ¥242.4B | ¥246.9B | −1.8% |
| Operating Income | ¥4.4B | ¥6.7B | −34.0% |
| Ordinary Income | ¥3.3B | ¥8.2B | −60.2% |
| Net Income | ¥3.6B | ¥7.2B | −49.5% |
| ROE | 1.8% | 3.8% | - |
Executive Summary
Cumulative results for 2026 Q3 showed a slight decline in revenue accompanied by significant deterioration across all profit measures, highlighting the low profitability of the core business. Revenue was ¥242.4B (-1.8% YoY), Operating Income was ¥4.4B (-34.0%), Ordinary Income was ¥3.3B (-60.2%), and Net Income attributable to owners of the parent was ¥3.3B (-51.6%). Although the decline in revenue was limited, the gross margin of 16.6% versus an SG&A ratio of 14.8% indicates weak fixed-cost absorption, and the deterioration in operating leverage substantially reduced profits. Ordinary Income declined more sharply than Operating Income due in part to an increase in non-operating expenses, including interest expenses.
Factors Affecting Performance
【Revenue】Revenue was ¥242.4B, down -1.8% YoY. As the Company operates in a single segment, a breakdown by business is not disclosed; however, the decline in revenue was limited, suggesting that a slight softening in demand and pricing, rather than a sharp quantitative contraction, was the primary factor.
【Profit and Loss】Operating Income was ¥4.4B (-34.0%), with the rate of profit decline significantly exceeding the revenue decline rate (-1.8%), indicating a pronounced deterioration in operating leverage due to the fixed-cost burden. Ordinary Income was ¥3.3B (-60.2%). Non-operating expenses of ¥3.4B, including ¥0.5B in interest expenses, exceeded non-operating income of ¥2.2B, primarily consisting of ¥1.7B in dividend income, resulting in a ¥1.1B non-operating loss and further downward pressure from Operating Income. Net Income was ¥3.3B (-51.6%). Although extraordinary income of ¥1.1B, consisting of gains on the sale of investment securities as a one-time factor, was recognized and boosted profit before tax, it was insufficient to offset the decline from the previous year. In conclusion, the Company experienced both lower revenue and lower profit.
Segment Analysis
As the Group operates in a single segment, segment-level revenue and profit-and-loss information is not disclosed.
Key Financial Metrics
【Profitability】The Operating Income margin of 1.8%, Net Income margin of 1.4%, and ROE of 1.8% all remained at low levels. A DuPont decomposition of ROE is 1.4% Net Income margin × 0.589x total asset turnover × 2.00x financial leverage, indicating that low profitability and asset efficiency, rather than leverage, are the primary causes of the low ROE.【Cash Quality】As actual Operating Cash Flow (OCF) is not disclosed, definitive conclusions should be avoided. However, trade receivables, consisting of accounts receivable and electronically recorded monetary claims totaling ¥94.1B, have an annualized collection period of 91 days, suggesting a structure in which the conversion of profit into cash requires considerable time. Inventories were ¥30.5B, accounting for 7.4% of total assets.【Investment Efficiency】ROIC is estimated at 2.5%, indicating limited profitability relative to invested capital. Investment securities of ¥106.6B account for 25.9% of total assets. While dividend income of ¥1.7B and gains on sales of ¥1.1B supplement profit, they should be evaluated separately from recurring business earnings.【Financial Soundness】The Equity Ratio of 49.9%, current ratio of 205.0%, and quick ratio of 174.8% indicate sound short-term payment capacity and capital stability. Interest-bearing debt was ¥57.8B, the Debt/Capital ratio was 22.0%, and interest coverage was 9.21x, indicating that financial leverage is not excessive.
Cash Flow Analysis
Actual Operating Cash Flow is not disclosed; therefore, no assessment is made of the coverage relationship between OCF and Net Income or of free cash flow. However, on the balance sheet, trade receivables, comprising accounts receivable of ¥80.2B and electronically recorded monetary claims of ¥13.9B, totaled ¥94.1B, with an annualized collection period of 91 days, indicating a prolonged collection cycle. Inventories were also recorded at ¥30.5B, including ¥14.5B in work in process, suggesting that asset accumulation in the manufacturing process may affect capital efficiency. Cash and deposits were ¥55.5B, increasing from ¥29.4B in the previous year, indicating that short-term funding capacity itself has been secured. Going forward, reducing trade receivables and inventories and confirming the extent to which OCF covers Net Income will be key to evaluating cash trends.
Earnings Quality
The composition of profit for the current period includes one-time factors and should be evaluated separately from recurring earnings power. Extraordinary income of ¥1.1B consisted entirely of gains on the sale of investment securities and represented the portion of profit before tax of ¥4.2B exceeding Ordinary Income of ¥3.3B. In addition, dividend income accounted for ¥1.7B of non-operating income of ¥2.2B, equivalent to approximately 38% of Operating Income of ¥4.4B, suggesting that investment income is supplementing core business profit. Meanwhile, comprehensive income was ¥15.0B, substantially exceeding Net Income of ¥3.3B. The difference was attributable to valuation changes, including ¥10.8B in valuation difference on other securities, representing an accrual-like element with a different nature from cash earnings. Based on the above, current-period profit has a relatively high dependence on investment-related income and valuation gains, and the earnings power of the core business alone should be viewed with greater caution.
Earnings Forecasts and Guidance
Progress against the full-year forecast was 71.3% for Revenue, 49.1% for Operating Income, 43.7% for Ordinary Income, and 60.0% for Net Income. Revenue is close to the standard progress level for cumulative Q3 results, with 75% as a general benchmark, but progress for Operating Income and Ordinary Income is substantially below the standard level. Accordingly, achieving the full-year plan would require approximately ¥4.6B in Operating Income and approximately ¥4.2B in Ordinary Income in Q4. The full-year forecast assumes Ordinary Income will decline -37.3% YoY, while Operating Income is expected to increase +8.6%, making a recovery in Q4 profitability a prerequisite for achieving the plan. As of the current quarter, the Company has not revised its earnings or dividend forecasts.
Shareholder Returns
The Q2 dividend was ¥0 per share, while the full-year dividend forecast is ¥4 per share. Based on forecast full-year Net Income of ¥5.5B, the Payout Ratio is approximately 27.1%, a conservative level below the 60% threshold commonly regarded as a guideline for sustainability. The forecast total dividend amount is approximately ¥1.5B, indicating that the cash dividend burden relative to forecast Net Income is limited. However, progress toward forecast full-year Net Income was only 60.0% as of Q3, and it will be necessary to confirm whether the full-year earnings plan underlying the dividend payment can be achieved.
Risk Factors
-
Profitability and operating leverage risk: With a gross margin of 16.6% versus an SG&A ratio of 14.8%, most gross profit is absorbed by fixed costs. Operating Income declined -34.0% compared with a -1.8% decline in Revenue, meaning that the impact on profit could be amplified if raw material prices rise or the Company is delayed in passing through higher costs.
-
Prolonged collection period for trade receivables: Annualized DSO reached 91 days against total accounts receivable and electronically recorded monetary claims of ¥94.1B. A prolonged collection period may tie up working capital and widen the time lag between recognizing profit and converting it into cash.
-
Dependence on investment securities for profit: Investment securities of ¥106.6B account for 25.9% of total assets, while dividend income of ¥1.7B and gains on sales of ¥1.1B supplemented current-period profit. This structure makes Net Income and comprehensive income susceptible to fluctuations in market prices and the timing of sales.
Industry Benchmark (Reference; Compiled by the Company)
Industry Benchmark (manufacturing)
Profitability and Returns
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Operating Income Margin | 1.8% | 8.6% (4.3%–12.7%) | −6.8pt |
| Net Income Margin | 1.5% | 6.4% (2.8%–10.3%) | −4.9pt |
Both the Operating Income margin and Net Income margin are substantially below the industry median, placing profitability toward the lower end of the industry.
Growth and Capital Efficiency
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Revenue Growth Rate (YoY) | −1.8% | 3.3% (-2.1%–8.9%) | −5.1pt |
The Revenue growth rate is also below the industry median, lagging the industry average, which is on a growth trajectory.
※Source: Compiled by the Company
Key Points from the Financial Results
-
While financial soundness, including an Equity Ratio of 49.9%, current ratio of 205.0%, and interest coverage of 9.21x, is strong, the profitability of the core business is below the industry average. The substantial room for improvement in the Operating Income margin of 1.8% and ROE of 1.8% is a key point of attention.
-
Progress against the full-year forecast was substantially below the standard progress level, with 49.1% for Operating Income and 43.7% for Ordinary Income versus a benchmark of 75%. The extent to which profit improvement is achieved in Q4 will be a key monitoring point.
-
Current-period Net Income was supported by non-core income, including gains on the sale of investment securities of ¥1.1B and dividend income of ¥1.7B. Tracking recurring earnings power excluding these items will be important in assessing earnings quality.
This report is an earnings analysis document automatically generated by AI based on XBRL earnings release data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly available earnings data. Investment decisions should be made at your own responsibility, after consulting professionals as necessary.
---End of Report---
AI Financial Analysis
Executive Summary
FY2026 Q3 performance was weak, with modest revenue contraction translating into a disproportionate decline in operating and ordinary earnings. Revenue was ¥24.24bn, down 1.8% year on year. Operating income fell 34.0% to ¥0.44bn. Ordinary income declined 60.2% to ¥0.33bn. Profit attributable to owners of parent fell 51.6% to ¥0.33bn. Gross profit decreased 3.0% to ¥4.03bn, while SG&A expenses increased 3.0% to ¥3.58bn. The gross margin narrowed by approximately 20bp year on year to 16.6%. The operating margin compressed by approximately 89bp to 1.8%, reflecting that the small revenue decline was not absorbed by the cost base. The attributable net margin contracted by approximately 141bp to 1.4%. The largest earnings pressure below operating income was the shift from equity-method income of ¥0.13bn in the prior year to equity-method losses of ¥0.13bn in the current period. Dividend income of ¥0.17bn remained an important contributor to non-operating income, equivalent to about half of ordinary income. Profit before tax of ¥0.42bn was supported by a ¥0.11bn gain on sales of investment securities, so reported bottom-line profit includes a non-recurring component. Comprehensive income nevertheless increased to ¥1.50bn from ¥1.03bn, principally reflecting a ¥1.08bn valuation gain on securities recognized in other comprehensive income. Liquidity is sound, with a 205.0% current ratio and cash of ¥5.55bn, but the earnings base is not generating an adequate return on capital. Annualized ROE is 2.1% and ROIC is 2.5%, both indicating low capital efficiency. The ¥34.0bn full-year revenue forecast implies a 71.3% Q3 progress rate, broadly near the normal 75% seasonal benchmark. However, operating-income progress is only 49.1%, requiring a substantial fourth-quarter recovery to meet the ¥0.90bn full-year target. The unchanged ¥4.00 full-year dividend forecast implies a modest 27.1% payout ratio based on forecast EPS of ¥14.75, but its sustainability depends on the expected earnings recovery being delivered.
Profitability Analysis
Annualized DuPont ROE is 2.1%, comprising a 1.4% net profit margin, 0.785x asset turnover, and 2.00x financial leverage. The principal constraint is profitability rather than turnover or leverage: the annualized net margin is well below the 8% level generally associated with adequate returns. The annualized EBIT margin of 1.8% is also the subject of the low-operating-efficiency alert, as it is below the 5% concern threshold. Gross margin declined from approximately 16.8% to 16.6%, a roughly 20bp deterioration, and is below the 20% benchmark highlighted in the low-gross-margin alert. More importantly, SG&A expenses rose 3.0% while revenue fell 1.8%, creating negative operating leverage and reducing operating income by 34.0%. Operating margin consequently fell from approximately 2.7% to 1.8%, a compression of about 89bp. The five-factor decomposition shows a 0.784 tax burden and 0.952 interest burden, indicating that tax and interest costs were not the principal drivers of weak returns. Interest coverage of 9.21x remains adequate, although interest expense rose to ¥0.48bn from ¥0.36bn. Below operating income, the move to ¥0.13bn of equity-method losses from ¥0.13bn of equity-method income in the prior period materially depressed ordinary income. Dividend income of ¥0.17bn supported earnings, but reliance on investment-related income is less durable than an improvement in the core chemical manufacturing margin. The ¥0.11bn securities-sale gain lifted profit before tax and represented 26% of profit attributable to owners, reducing the recurrence quality of reported net income. The capital-efficiency alert is warranted: annualized ROIC of 2.5% is below 5%, implying that the substantial asset base, including ¥10.66bn of investment securities and ¥9.07bn of PPE, is not currently producing sufficient operating profit.
Growth Assessment
Revenue declined 1.8% year on year to ¥24.24bn, indicating that growth has not yet offset margin and fixed-cost pressure. The decline in gross profit was milder than the decline in operating profit, which indicates that the more significant deterioration occurred in the SG&A-to-sales relationship rather than gross margin alone. Full-year management guidance calls for 4.0% revenue growth to ¥34.0bn and 8.6% operating-income growth to ¥0.90bn. Q3 revenue progress is 71.3% of the full-year forecast, only 3.7 percentage points below the standard 75% Q3 run rate. In contrast, operating-income progress is 49.1%, 25.9 percentage points below the standard run rate. Ordinary-income progress is 43.7% of forecast, 31.3 percentage points below the standard run rate. Profit attributable to owners has reached 60.0% of the ¥0.55bn forecast, 15.0 percentage points below the standard run rate. Achieving guidance therefore requires approximately ¥9.76bn of Q4 revenue, ¥0.46bn of operating income, and ¥0.22bn of attributable profit. The implied Q4 operating margin is approximately 4.7%, materially above the Q3 cumulative 1.8% margin. The required Q4 margin recovery is the central operational test for the outlook. The company operates as a single segment, so no segment-level source of the earnings pressure or recovery is available. The forecast was not revised, preserving management's expectation of a fourth-quarter improvement, but the degree of required profit acceleration raises execution sensitivity.
Financial Health
Liquidity is healthy. Current assets of ¥20.76bn exceed current liabilities of ¥10.13bn, producing working capital of ¥10.63bn and a current ratio of 205.0%. The quick ratio of 174.8% also indicates that near-term obligations are well covered without reliance on inventory liquidation. Cash and deposits increased ¥2.61bn year on year to ¥5.55bn, an 88.7% rise. Cash is 16.33x short-term loans of ¥0.34bn, limiting immediate refinancing risk. Interest-bearing debt totals ¥5.78bn, comprising ¥0.34bn of short-term loans and ¥5.44bn of long-term loans. Debt/capital is 22.0%, comfortably below the 40% investment-grade benchmark. The reported debt-to-equity ratio is 1.00x, at the conservative/aggressive dividing line but well below the 2.0x level that would indicate aggressive leverage. The debt maturity profile is broadly balanced because current assets substantially exceed current liabilities and only a small portion of borrowings is short term. Current portions of long-term loans total ¥2.07bn and should remain manageable given cash and liquid current assets. Long-term loans increased ¥0.68bn year on year to ¥5.44bn, while short-term loans rose 25.9% to ¥0.34bn; the funding increase should be monitored because operating profitability weakened. Total equity increased ¥1.56bn to ¥20.55bn, supported by retained earnings and valuation gains on securities. Investment securities rose ¥0.71bn to ¥10.66bn and represent 25.9% of total assets, making equity-market valuation movements material to book value and comprehensive income. Asset retirement obligations of ¥0.79bn equal approximately 3.8% of total liabilities, an elevated environmental-obligation level for a chemical manufacturer that warrants ongoing monitoring. Defined-benefit liabilities of ¥1.66bn are another meaningful noncurrent obligation. Intangible assets increased from ¥0.28bn to ¥0.84bn, but remain only 0.2% of assets and do not create a material intangible-asset concentration risk.
Notable B/S Changes
Cash and deposits: +¥2.61bn (+88.7%) to ¥5.55bn - materially strengthens near-term liquidity and coverage of short-term borrowings. Long-term loans: +¥0.68bn (+14.3%) to ¥5.44bn - additional long-term funding increases leverage exposure despite still-moderate 22.0% debt/capital. Investment securities: +¥0.71bn (+7.2%) to ¥10.66bn - balance exceeds ¥5.0bn in absolute size and represents 25.9% of assets, increasing sensitivity of equity to market valuations. Intangible assets: +¥0.56bn (+200.0%) to ¥0.84bn - percentage growth is large but the balance remains immaterial at 0.2% of total assets. Accounts payable: +¥0.96bn (+18.8%) to ¥6.05bn - higher supplier financing partly offsets increased receivables and inventory-related working-capital needs.
Cash Flow Quality
The current earnings profile has a recurrence issue because profit before tax includes a ¥0.11bn gain on sales of investment securities, while ordinary income was weakened by ¥0.13bn of equity-method losses. The securities-sale gain was partly offset by a ¥0.02bn loss on sale of investment securities. Dividend income of ¥0.17bn also accounts for a meaningful portion of non-operating income and should be distinguished from the underlying operating result. Cash and deposits increased to ¥5.55bn from ¥2.94bn, providing additional liquidity support. Accounts receivable increased to ¥8.02bn from ¥7.57bn, while electronically recorded monetary claims increased to ¥1.39bn from ¥1.28bn. The quality alert identifies annualized DSO of 91 days, above the 60-day warning level and a material working-capital risk for a manufacturer. Slow customer collections can restrain cash conversion and increase credit-risk sensitivity even when reported revenue is stable. Trade payables increased to ¥6.05bn from ¥5.09bn, partly financing the increase in receivables and inventory-related working capital. Inventories increased to ¥3.05bn from ¥2.94bn; raw materials were ¥1.07bn and work in process was ¥1.45bn. The working-capital position should be monitored for evidence that receivable growth is being converted into cash rather than being financed through supplier credit and additional borrowing.
Dividend Sustainability
The full-year dividend forecast is ¥4.00 per share, with no revision announced. Based on forecast EPS of ¥14.75, the forecast dividend payout ratio is approximately 27.1%, below the 60% sustainability benchmark. Based on Q3 cumulative EPS of ¥8.87, the forecast annual dividend already represents approximately 45.1% of earnings recorded to date. The absence of a Q2 dividend is consistent with the disclosed interim dividend structure. The forecast payout is modest relative to book value per share of ¥518.31 and total equity of ¥20.55bn. Liquidity is also supportive, with ¥5.55bn of cash and a 205.0% current ratio. However, dividend capacity is ultimately more dependent on restoration of operating profitability than on valuation gains in investment securities. The company needs to deliver the forecast fourth-quarter operating-income recovery for the dividend outlook to remain supported by recurring earnings.
Risk Assessment
Business risks include Margin risk is high: the gross margin is only 16.6% and the operating margin is 1.8%, leaving limited capacity to absorb changes in selling prices, feedstock costs, energy costs, or plant utilization., The low-gross-margin alert is significant because a roughly 20bp year-on-year gross-margin decline, combined with a 1.8% revenue decline, was sufficient to contribute to a 34.0% operating-income decline., The chemical manufacturing business remains exposed to raw-material and energy-price volatility, environmental regulation, and plant-operation or product-quality disruptions., Annualized DSO of 91 days is above the 60-day warning threshold. This high-receivable-days alert points to slow collection, greater customer-credit exposure, and potentially weaker cash conversion., The shift from equity-method income of ¥0.13bn to equity-method losses of ¥0.13bn demonstrates sensitivity to affiliate performance outside the core operating result..
Financial risks include Annualized ROIC of 2.5% and ROE of 2.1% indicate weak capital productivity. The capital-efficiency alert implies a risk that the asset base and funding structure do not earn adequate returns if margins fail to recover., Long-term loans rose to ¥5.44bn and interest expense rose to ¥0.48bn. Interest coverage remains sound at 9.21x, but lower operating profit reduces the cushion against future borrowing-cost increases., Investment securities total ¥10.66bn, or 25.9% of assets. Their valuation is a material source of equity and comprehensive-income volatility, as shown by ¥1.08bn of valuation gains on securities in the period., Asset retirement obligations of ¥0.79bn, or approximately 3.8% of liabilities, create an elevated environmental-remediation and decommissioning exposure for a chemical manufacturer..
Key concerns include Meeting unchanged full-year operating-income guidance requires approximately ¥0.46bn of Q4 operating income and an implied 4.7% Q4 operating margin, versus a 1.8% Q3 cumulative margin., Profit attributable to owners includes a ¥0.11bn securities-sale gain, equivalent to about 26% of attributable profit, which lowers the recurrence quality of reported earnings., SG&A expenses increased 3.0% despite a 1.8% revenue decline, creating negative operating leverage., The combination of low operating efficiency, low gross margin, and low ROIC is the primary risk to the durability of the earnings recovery..
Investment Implications
Key takeaways include Revenue was broadly stable, but operating income fell 34.0%, highlighting a weak margin structure and unfavorable operating leverage., The balance sheet provides substantial near-term resilience through a 205.0% current ratio, ¥5.55bn of cash, and 22.0% debt/capital., The earnings base is low quality relative to reported bottom-line profit because of the ¥0.11bn securities-sale gain and meaningful reliance on dividend income., Unchanged full-year guidance requires a sharp Q4 operating-margin recovery, making execution against pricing, volumes, and SG&A control the principal near-term determinant., The ¥4.00 forecast annual dividend has a modest 27.1% payout ratio against forecast EPS, but recurring operating-profit recovery remains important to its support..
Metrics to watch include Operating margin and gross margin, particularly progress toward the implied 4.7% Q4 operating margin., SG&A growth relative to revenue growth., Annualized DSO of 91 days, receivables, and electronically recorded monetary claims., Equity-method investment performance following the move to ¥0.13bn of losses., Interest expense, long-term loan balances, and interest coverage., Investment-security valuation movements and their effect on other comprehensive income and equity., ROIC and annualized ROE improvement from 2.5% and 2.1%, respectively..
Regarding relative positioning, The company combines strong liquidity and moderate debt/capital with materially weak profitability and capital efficiency. Relative to standard manufacturing benchmarks, its 1.8% operating margin, 16.6% gross margin, 2.5% annualized ROIC, and 91-day annualized DSO indicate an operating profile that requires improvement despite a resilient balance sheet.